Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional profiling of mouse embryonic fibroblasts harboring the Fxn G127V mutation

ABSTRACT: Transcriptional profiling of mouse embryonic fibroblasts harboring the Fxn G127V mutation

PROVIDER: PRJNA1076569 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28083219_1.fastq.gz	Fastqsanger.gz
	SRR28083219_2.fastq.gz	Fastqsanger.gz
	SRR28083220_1.fastq.gz	Fastqsanger.gz
	SRR28083220_2.fastq.gz	Fastqsanger.gz
	SRR28083221_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Transcriptional profiling of mouse embryonic fibroblasts harboring the Fxn G127V mutation

Project description:Friedreich's ataxia (FRDA) is a neurodegenerative disease caused by mutations in the frataxin (FXN) gene. In this study, we immortalized mouse embryonic fibroblasts (MEFs) derived from G127V Fxn mutant mice and compared them to the wild-type (WT) MEFs. Mutant G127V MEFs demonstrated decreased cell proliferation and ATP production, as well as an increase in reactive oxygen species (ROS) production when compared to WT cells. These phenotypes are partially corrected by exogenous expression of frataxin. Surprisingly, extended passaging of immortalized G127V Fxn MEFs improves their proliferation, and alleviates ATP deficiency as well as decreases ROS levels despite persistent frataxin deficiency. We defined gene expression changes associated with phenotypic adaptation of G127V mutant MEFs by comparing transcriptional profiles of early and late passage G127V MEFs with WT cells.

2025-01-22 | GSE255810 | GEO

Correction of splicing defect in compound heterozygous FRDA patient carrying FXN 165+5G>C point mutation.

Project description:Friedreich’s ataxia is an autosomal recessive disease caused by mutations in the FXN gene. Approximately 95% of patients harbor homozygous GAA repeat expansion in the intron 1 of the FXN, while the remaining 5% are compound heterozygotes carrying GA expansion on 1 allele and point mutation on the other allele. Here, we characterized a G to C transversion in position 5 of the intron 1 of the FXN. Mutation results in profound downregulation of FXN mRNA and protein levels. Transcriptome and RT-PCR analyses demonstrated aberrant splicing of the FXN gene caused by this mutation that can be at least in part corrected with antisense oligonucleotides (ASOs) targeting intron 1.

2025-07-10 | GSE262763 | GEO

Metabolomics Workbench ST000003 - GNPS - Metabolomic analysis of mouse embryonic fibroblasts, embryonic stem cells, and induced pluripotent stem cells

Project description:mouse embryonic fibroblasts, embryonic stem cells, and induced pluripotent stem cells were compared via metabolomic analysis

2018-08-02 | MSV000082680 | GNPS

Gene expression profiling of fibroblasts harboring POC1A mutation

Project description:POC1A encodes a WD repeat protein localizing to centrioles and spindle poles and associated with Short stature, onychodysplasia, facial dysmorphism and hypotrichosis (SOFT) syndrome (OMIM #614813). In our study, we reported on two patients with primordial dwarfism (PD) from the same family. We utilized Whole Exome Sequencing (WES) in the patients to screen all PD related genes and to define putative novel candidate genes. A novel homozygous p.T120A missense mutation was detected in POC1A, a known causative gene of SOFT syndrome, and confirmed using Sanger sequencing. To confirm the pathogenicity of the detected mutation, primary fibroblast cultures obtained from the patients and a control individual were used. Gene expression profiles of the fibroblast cultures were taken. We performed gene expression arrays on fibroblasts cultured from patients with SOFT syndrome and POC1A mutation and compared their expression profiles to that of control fibroblast cells.

2015-07-15 | E-GEOD-66314 | biostudies-arrayexpress

Gene expression altered by Sox2 T258A mutation in mouse embryonic stem cells

Project description:mRNA expression profiles of mouse embryonic stem cells harboring Sox2 WT and a Sox2 T258A mutation

2021-06-06 | GSE176211 | GEO

Human Mitochondria NFS1-ISCU-FXN XL-MS

Project description:Frataxin (FXN) is involved in mitochondrial iron-sulfur (Fe-S) cluster biogenesis and serves to accelerate Fe-S cluster formation. FXN deficiency is associated with Friedreich ataxia, a neurodegenerative disease. Using chemical cross-linking (XL) accompanied with LC-MS/MS, we studied the the interaction between the core complexes Acp-ISD11-NFS1 (AIN) and AIN-ISCU (AINU) with FXN.

2018-07-11 | PXD006938 | Pride

Human Mitochondrial NFS1-FXN XL LS-MS/MS

2018-07-11 | PXD006928 | Pride

Expression profiling following Nrf2D29H or Keap1R554Q expression in mouse embryonic fibroblasts

Project description:We generated mouse embryonic fibroblasts from genetically engineered mouse models harboring conditional alleles of Nfe2l2(Nrf2)D29H and Keap1R554Q and induced expresison of these mutations using adenoviral Cre. Gene expression was profiled.

2023-02-23 | GSE212942 | GEO

Total RNA sequencing of FXN knockdown in pulmonary artery endothelial cells

Project description:This data set provides different RNA expression data for primary human pulmonary endothelial cells with and without FXN deficiency achieved by RNAi transfection in an effort to understand the endothelial-specific effects of acquired frataxin (FXN) deficiency and their implications for pulmonary vascular disease.

2021-04-09 | GSE171692 | GEO

Transcriptome of Dp1Tyb and wild-type mouse embryonic fibroblasts

Project description:Purpose: to identify the effects of the Dp1Tyb mutation on the transcriptome of mouse embryonic fibroblasts

2019-03-29 | GSE109293 | GEO